![]() |
市場調查報告書
商品編碼
1753883
2025 年至 2033 年腦監測市場報告(按產品類型、程序、應用、最終用戶和地區)Brain Monitoring Market Report by Product Type, Procedure, Application, End User, and Region 2025-2033 |
2024年,全球腦監測市場規模達68億美元。展望未來,預計到2033年,該市場規模將達到111億美元,2025-2033年期間的複合年成長率(CAGR)為5.6%。神經系統疾病發生率的上升、腦監測設備的技術進步、人們對腦健康的日益關注以及人口老化是推動市場成長的主要因素。
神經系統疾病盛行率上升
神經系統疾病盛行率的上升是影響腦監測市場成長的重要因素。隨著全球人口老化,與年齡相關的神經系統疾病(例如阿茲海默症和帕金森氏症)的發病率也在上升。例如,根據美國國家醫學圖書館發表的一篇文章,人口老化顯著增加了各種神經系統疾病的社會負擔,包括阿茲海默症、原發性惡性腦瘤、帕金森氏症和肌萎縮側索硬化症。此外,根據世界衛生組織 (WHO) 的數據,近 14% 的 60 歲及以上成年人患有精神疾病。此外,隨著神經系統疾病變得越來越普遍,對用於準確檢測和監測這些疾病的先進診斷工具的需求也日益成長。腦部監測技術,例如腦電圖 (EEG)、磁振造影 (MRI) 和正子斷層掃描 (PET) 掃描,在神經系統疾病的診斷和評估中發揮著至關重要的作用。例如,2024年4月,非侵入性腦刺激和協同監測技術供應商Soterix Medical Inc.推出了MxN-GO EEG,這是一款高清經顱電刺激(HD-tES)和腦電圖系統,具有獨特的無線設計。該技術專為需要在移動和自然環境中進行電刺激和監測腦活動的研究應用而設計。這些因素進一步促進了市場的成長。
腦電圖(EEG)的應用日益廣泛
腦電圖 (EEG) 的應用日益廣泛,大大推動了腦監測市場的成長。 EEG 對於診斷各種神經系統疾病(例如癲癇、睡眠障礙和腦腫瘤)至關重要。它能夠檢測腦內異常電活動,有助於準確診斷、指導治療決策並改善患者預後。例如,2022 年 7 月,美國國立衛生研究院 (NIH) 對美國醫院進行了一項調查,發現使用 EEG 設備顯著提高了醫生對腦電圖癲癇的診斷能力。與臨床診斷相比,EEG 癲癇診斷的敏感度從 77.8% 提高到 100%,特異性從 63.9% 提高到 89%。 EEG 技術的不斷進步,例如高密度 EEG、攜帶式設備和改進的訊號處理技術,增強了其診斷能力和可用性。例如,2024年4月,NeuroVigil在美國推出了iBrain個人腦監測器,這是一款處於研究階段的攜帶式設備,可以非侵入式地記錄神經系統疾病患者的腦電活動。 iBrain基於腦電圖(EEG)技術,該技術常用於評估腦電活動和檢測神經系統異常。患者可以在家中和睡眠期間使用該設備,更有效率、更輕鬆地取得腦電圖資料。這些技術改進使腦電圖在各種醫療環境中更易於獲取且更可靠,促進了腦電圖的廣泛應用和市場擴張。這些因素進一步提升了腦監測市場的佔有率。
新興神經科學研究
日益成長的神經科學研究正在促進大腦監測市場的成長。神經科學研究不斷突破腦部造影技術的界限,例如MRI(磁振造影)、PET(正子斷層掃描)、CT(電腦斷層掃描)和EEG(腦電圖)。例如,通用電氣醫療集團(GE HealthCare)於2024年5月推出了SIGNA MAGNUS,這是一款尖端的頭部磁振造影(MRI)掃描儀。 SIGNA MAGNUS是一項重大進步,它為科學家提供了強大的工具來深入研究大腦的複雜性。這些技術對於可視化和理解健康個體和神經系統疾病患者的大腦結構、功能和連結至關重要。此外,神經科學研究也擴大利用人工智慧和機器學習演算法來分析大規模腦部造影和腦電圖資料。這些先進的分析工具增強了對複雜大腦活動模式的解讀,識別細微的生物標記物,並預測疾病進展。此外,各種組織正在推動人工智慧在腦部疾病中的應用,以提供更好的診斷。例如,2024年2月,獨立非營利組織「萬腦計畫」(10,000 Brains Project)成立,旨在推動人工智慧(AI)在對抗阿茲海默症、帕金森氏症和其他神經系統疾病方面的倫理應用。該組織的目標是提供所需的領導力、經驗和資金支持,確保研究人員能夠迅速採用這項強大的新技術,為有需要的患者提供更好的診斷和治療。這些因素進一步推高了市場需求。
The global brain monitoring market size reached USD 6.8 Billion in 2024. Looking forward, the market is expected to reach USD 11.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.6% during 2025-2033. Growing incidences of neurological disorders, technological advancements in brain monitoring devices, surging focus on brain health, and aging population are primarily driving the market growth.
Rising Prevalence of Neurological Disorders
The rising prevalence of neurological disorders is a significant factor influencing the growth of the brain monitoring market. As populations around the world age, the incidence of age-related neurological disorders such as Alzheimer's disease and Parkinson's disease increases. For instance, according to an article published by the National Library of Medicine, the aging population has significantly increased the societal burden of various neurologic illnesses, including Alzheimer's disease, primary malignant brain tumors, Parkinson's disease, and amyotrophic lateral sclerosis. Moreover, according to the World Health Organization (WHO), nearly 14% of adults aged 60 and above live with a mental disorder. Apart from this, as neurological disorders become more prevalent, there is a growing need for advanced diagnostic tools to accurately detect and monitor these conditions. Brain monitoring technologies such as EEG (electroencephalography), MRI (magnetic resonance imaging), and PET (positron emission tomography) scans play a crucial role in the diagnosis and assessment of neurological disorders. For instance, in April 2024, Soterix Medical Inc., a non-invasive brain stimulation and synergistic monitoring technologies provider, launched MxN-GO EEG, a high-definition transcranial Electrical Stimulation (HD-tES) and EEG system with a unique untethered design. The technology is designed for research applications that need electrical stimulation and monitoring of brain activity in mobile and natural settings. These factors are further proliferating the market growth.
Increasing Application of Electroencephalography (EEG)
The increasing application of Electroencephalography (EEG) is significantly driving the growth in the brain monitoring market. EEG is essential for diagnosing various neurological disorders such as epilepsy, sleep disorders, and brain tumors. Its ability to detect abnormal electrical activity in the brain helps in accurate diagnosis, guiding treatment decisions and improving patient outcomes. For instance, in July 2022, the National Institute of Health performed a survey of hospitals in the United States and discovered that using EEG equipment dramatically improved electrographic seizure diagnosis by physicians. The sensitivity of electrographic seizure diagnosis increased from 77.8% to 100%, while the specificity increased from 63.9% to 89% when compared to clinical diagnosis. Continuous advancements in EEG technology, such as high-density EEG, portable devices, and improved signal processing techniques, enhance its diagnostic capabilities and usability. For instance, in April 2024, NeuroVigil introduced the iBrain personal brain monitor in the United States, which is an investigational portable gadget that can non-invasively record electrical activity in persons with neurological problems. iBrain is based on electroencephalogram (EEG) technology, which is routinely used to assess brain electrical activity and detect neurological abnormalities. Patients can use the gadget at home and during sleep to acquire EEG data more efficiently and easily. These technological improvements make EEG more accessible and reliable across diverse healthcare settings, fostering broader adoption and market expansion. These factors are further contributing to the brain monitoring market share.
Emerging Neuroscience Research
Increasing neuroscience research is contributing to the growth of the brain monitoring market. Research in neuroscience continually pushes the boundaries of brain imaging technologies such as MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), CT (Computed Tomography), and EEG (Electroencephalography). For instance, in May 2024, GE HealthCare unveiled SIGNA MAGNUS, a cutting-edge head-only magnetic resonance imaging (MRI) scanner. SIGNA MAGNUS is a major advancement that gives scientists a strong instrument to examine the intricacies of the brain in depth. These technologies are crucial for visualizing and understanding brain structure, function, and connectivity in both healthy individuals and those with neurological disorders. Besides this, neuroscience research increasingly leverages AI and machine learning algorithms to analyze large-scale brain imaging and EEG data. These advanced analytical tools enhance the interpretation of complex brain activity patterns, identify subtle biomarkers, and predict disease progression. Also, various organizations are promoting applications of artificial intelligence in brain illnesses in order to provide better diagnostics. For instance, in February 2024, the 10,000 Brains Project, an independent non-profit organization, was launched to promote the ethical application of artificial intelligence (AI) in the battle against Alzheimer's, Parkinson's, and other neurological illnesses. The organization's aim is to provide the leadership, experience, and financial assistance required to ensure that researchers can quickly adopt this powerful new technology in the pursuit of better diagnostics and treatments for patients in need. These factors are further escalating the market demand.
The demand for electroencephalography (EEG) devices is driven by the surging prevalence of epilepsy and sleep disorders. Moreover, magnetoencephalography (MEG) devices are essential for pre-surgical localization of epileptic foci and brain tumor mapping. Apart from this, the increasing incidence of stroke requiring monitoring of cerebral blood flow is bolstering the demand for transcranial doppler devices. Besides this, the demand for intracranial pressure monitors is driven by the rising cases of traumatic brain injury.
High demand in intensive care units (ICUs) for monitoring patients with traumatic brain injury, intracranial hemorrhage, and hydrocephalus is driving the demand for invasive procedures. This procedure is essential for optimizing management during neurosurgical procedures such as tumor resection or placement of shunts. Non-invasive procedures are widely used for diagnosing epilepsy and sleep disorders, and monitoring brain function in stroke, coma, and neurodegenerative diseases. Moreover, it is also utilized in neuroscience research due to accessibility and real-time monitoring capabilities.
According to the brain monitoring market overview, the demand for brain monitoring technologies in the context of specific neurological conditions such as Parkinson's disease, traumatic brain injury (TBI), epilepsy, dementia, and sleep disorders is driven by various clinical needs, advancements in technology, and research initiatives. In Parkinson's disease, there is a high demand for invasive brain monitoring techniques like intraoperative microelectrode recording (MER) and intraoperative macrostimulation (IOM). Moreover, in traumatic brain injury, intracranial pressure (ICP) monitoring is essential to manage elevated ICP levels, which can lead to secondary brain injury post-TBI, guiding treatment strategies, and improving patient outcomes.
According to the brain monitoring market analysis, hospitals use brain monitoring technologies such as CT scans and MRI to quickly diagnose and assess stroke patients. These imaging modalities help determine the type of stroke (ischemic or hemorrhagic) and guide immediate treatment decisions. While neurodiagnostic centers utilize a range of brain monitoring technologies to conduct comprehensive evaluations for patients with complex neurological symptoms. This includes EEG for seizure monitoring, MEG for functional brain mapping, and PET scans for assessing metabolic activity in the brain.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
High adoption of advanced neuroimaging in United States and Canada, technologies such as MRI, CT, and PET scans in hospitals and diagnostic centers are driving the growth in North America region. Moreover, the growth in Europe is driven by a strong focus on neuroscience research, utilizing functional imaging and EEG for understanding brain function and disorders. Apart from this, the rapidly expanding healthcare infrastructure in Asia Pacific with the increasing availability of MRI and CT scans is driving the market growth in the region.